These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 8468487)

  • 1. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation.
    Tomhave ED; Richardson RM; Didsbury JR; Menard L; Snyderman R; Ali H
    J Immunol; 1994 Oct; 153(7):3267-75. PubMed ID: 8089498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization.
    Ali H; Richardson RM; Tomhave ED; Didsbury JR; Snyderman R
    J Biol Chem; 1993 Nov; 268(32):24247-54. PubMed ID: 8226971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
    Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
    J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation, dephosphorylation, and recycling of the C5a receptor in differentiated HL60 cells.
    Giannini E; Boulay F
    J Immunol; 1995 Apr; 154(8):4055-64. PubMed ID: 7706744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells.
    Prossnitz ER; Quehenberger O; Cochrane CG; Ye RD
    J Immunol; 1993 Nov; 151(10):5704-15. PubMed ID: 8228256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
    Suvorova ES; Gripentrog JM; Miettinen HM
    Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of wild-type and catalytically inactive forms of GRK2 and GRK6 fails to alter the agonist-induced phosphorylation of the C5a receptor (CD88): evidence that GRK6 is autophosphorylated in COS-7 cells.
    Milcent MD; Christophe T; Rabiet MJ; Tardif M; Boulay F
    Biochem Biophys Res Commun; 1999 May; 259(1):224-9. PubMed ID: 10334944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators.
    Katona IM; Ohura K; Allen JB; Wahl LM; Chenoweth DE; Wahl SM
    J Immunol; 1991 Jan; 146(2):708-14. PubMed ID: 1898961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms.
    Gilbert TL; Bennett TA; Maestas DC; Cimino DF; Prossnitz ER
    Biochemistry; 2001 Mar; 40(12):3467-75. PubMed ID: 11297412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
    Tsu RC; Allen RA; Wong YH
    Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
    Mery L; Boulay F
    J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity.
    Richardson RM; Ali H; Tomhave ED; Haribabu B; Snyderman R
    J Biol Chem; 1995 Nov; 270(46):27829-33. PubMed ID: 7499254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
    Kodama T; Hazeki K; Hazeki O; Okada T; Ui M
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase.
    Rane MJ; Carrithers SL; Arthur JM; Klein JB; McLeish KR
    J Immunol; 1997 Nov; 159(10):5070-8. PubMed ID: 9366435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.